PAR paradigm biopharmaceuticals limited..

The Heartfelt addressing..., page-9

  1. 363 Posts.
    lightbulb Created with Sketch. 42
    I agree for 2022 the big what IF is DMOAD.....this is an incredibly crucial result for PAR and the readout for 008 in Q3 is one I wait for.

    IF it not shown to have DMOAD then PAR will take a big hit.....

    IF it is shown to be DMOAD then I feel this will be a massive barrier removed

    Then the realms of being a blockbuster drug are far more likely, rather than another pill on the shelf.

    All IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.8¢
Change
0.018(4.38%)
Mkt cap ! $165.9M
Open High Low Value Volume
40.0¢ 42.0¢ 39.5¢ $106.2K 261.7K

Buyers (Bids)

No. Vol. Price($)
2 6810 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 39155 5
View Market Depth
Last trade - 11.19am 22/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.